Segasist Awaits 510(k) Clearance For "Self-Training" Auto-Contouring Tool
This article was originally published in The Gray Sheet
Executive SummarySegasist expects FDA to decide as early as this month on a 510(k) submission for a prostate-contouring software system designed to "learn" as it goes and become more and more accurate the more it is used.
You may also be interested in...
Companion diagnostics are needed increasingly by pharma companies to justify the safety and effectiveness of their products. With specific first-time EU regulation of these products within sight – and urgently needed – is there a risk of delays to these products being able to demonstrate compliance?